SG Americas Securities LLC Has $1.29 Million Position in CVS Health Co. (NYSE:CVS)

SG Americas Securities LLC boosted its position in shares of CVS Health Co. (NYSE:CVSFree Report) by 47.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 28,801 shares of the pharmacy operator’s stock after buying an additional 9,234 shares during the quarter. SG Americas Securities LLC’s holdings in CVS Health were worth $1,293,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. MidAtlantic Capital Management Inc. acquired a new position in shares of CVS Health during the third quarter valued at $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health during the 3rd quarter worth about $31,000. Legacy Investment Solutions LLC acquired a new position in CVS Health during the 3rd quarter valued at about $31,000. Reston Wealth Management LLC bought a new position in shares of CVS Health in the 3rd quarter valued at about $32,000. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in shares of CVS Health during the 3rd quarter worth approximately $33,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Performance

CVS opened at $56.20 on Tuesday. The company has a market capitalization of $70.72 billion, a price-to-earnings ratio of 14.26, a P/E/G ratio of 0.80 and a beta of 0.59. The business’s 50-day moving average price is $51.24 and its two-hundred day moving average price is $56.20. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVSGet Free Report) last announced its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same quarter last year, the firm earned $2.21 EPS. CVS Health’s revenue for the quarter was up 6.3% compared to the same quarter last year. Equities analysts expect that CVS Health Co. will post 5.22 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.73%. The ex-dividend date is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on CVS shares. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective on the stock in a research note on Tuesday, December 3rd. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a report on Tuesday, October 1st. Truist Financial reduced their target price on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, Barclays lowered their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $68.12.

Read Our Latest Research Report on CVS

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

See Also

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.